Roles of interferon and natural killer cells in the antiviral activity of 7-thia-8-oxoguanosine against Semliki Forest virus infections in mice.
7-Thia-8-oxoguanosine is a novel biological response modifier with broad-spectrum antiviral activity against many DNA and RNA viruses in vivo. Since two of its properties are to induce interferon and to activate natural killer (NK) cells, we investigated the roles of the lymphokine and NK cells in the antiviral activity of the compound against Semliki Forest virus. Antibody to interferon alpha/beta could completely abolish the protective activity of the nucleoside against virus infection in mice, whereas antibodies to interferons beta and gamma could not, indicating that interferon alpha was of major importance to confer protection to the animals. Reduced activation of NK cells was also observed in mice treated with 7-thia-8-oxoguanosine and antibody to interferon alpha/beta. The role of NK cells in the protective activity of the compound was directly assessed in beige mice or in Swiss Webster mice treated with asialo GM1 antibody. In both experiments, the animals were protected from lethal virus infection by treatment with nucleoside. Spleen cells primed by 7-thia-8-oxoguanosine and adoptively transferred to untreated mice could not save them from virus-induced mortality. These three results provide evidence that natural killer cells activated by 7-thia-8-oxoguanosine play a minimal role in protection from acute Semliki Forest virus infections in mice.
Nucleic Acid Research Institute, Costa Mesa, CA 92626.
D F
DF
Smee
H A
HA
Alaghamandan
A
A
Jin
B S
BS
Sharma
W B
WB
Jolley
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D004359:Drug Therapy, Combination; D005260:Female; D006151:Guanosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D007372:Interferons / Q000502:physiology*; D007694:Killer Cells, Natural / Q000276:immunology*; D007928:Lethal Dose 50; D051379:Mice; D008810:Mice, Inbred C57BL; D012672:Semliki forest virus / Q000187:drug effects* / Q000276:immunology; D014036:Togaviridae Infections / Q000188:drug therapy* / Q000276:immunology
D000914:Antibodies, Viral; D006151:Guanosine; C061136:isatoribine; D007372:Interferons